ERBB2 and esophageal cancer: Of note, a patient with metastatic HER2 3+ esophageal cancer achieved a PR after 8 cycles that lasted for 25 weeks and a patient with HER2 2+ metastatic gastric cancer had stabilization of disease that was maintained for 62 weeks.